Pfizer, Alnylam and BMS take note: the U.S. is poised to see ‘a staggering number’ of cardiomyopathy cases this decade July 11, 2022https://www.fiercepharma.com/marketing/pfizer-alnylam-and-bms-take-note-us-poised-see-staggering-number-cardiomyopathy-cases
